Gland Pharma Limited (GLAND) — Cash Flow Reinvestment Rate
Gland Pharma Limited (GLAND) has a Cash Flow Reinvestment Rate of 0.33x as of September 2025, reinvesting Rs1.94 Billion (capex Rs1.94 Billion ) from operating cash flow of Rs5.93 Billion. Check Gland Pharma Limited (GLAND) cash flow quality to evaluate the quality of earnings relative to operating cash generation.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Gland Pharma Limited Cash Flow Reinvestment Rate (2017–2026)
Historical reinvestment intensity for Gland Pharma Limited across 10 annual periods. Explore Gland Pharma Limited (GLAND) cash flow to debt to assess how comfortably operating cash covers total debt obligations.
Annual Cash Flow Reinvestment Rate for Gland Pharma Limited (2017–2026)
Year-by-year capital reinvestment analysis for Gland Pharma Limited. For live market cap and broader valuation context, see how much is Gland Pharma Limited worth.
| Year | Reinvestment Rate | Total Reinvested (INR) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2026 | 0.72x | Rs8.90 Billion | Rs12.31 Billion | Rs4.91 Billion | ▼ -68.4% |
| 2025 | 2.28x | Rs20.89 Billion | Rs9.15 Billion | Rs3.85 Billion | ▲ +6.0% |
| 2024 | 2.15x | Rs21.47 Billion | Rs9.97 Billion | Rs3.90 Billion | ▼ -45.2% |
| 2023 | 3.93x | Rs14.31 Billion | Rs3.64 Billion | Rs2.23 Billion | ▲ +174.3% |
| 2022 | 1.43x | Rs11.34 Billion | Rs7.91 Billion | Rs5.22 Billion | ▼ -45.3% |
| 2021 | 2.62x | Rs15.86 Billion | Rs6.05 Billion | Rs2.29 Billion | ▲ +120.6% |
| 2020 | 1.19x | Rs8.33 Billion | Rs7.01 Billion | Rs1.95 Billion | ▼ -37.9% |
| 2019 | 1.91x | Rs3.54 Billion | Rs1.85 Billion | Rs1.36 Billion | ▲ +0.9% |
| 2018 | 1.90x | Rs3.83 Billion | Rs2.02 Billion | Rs851.75 Million | ▲ +118.1% |
| 2017 | 0.87x | Rs4.14 Billion | Rs4.76 Billion | Rs1.16 Billion | — |